New hope for patients with pulmonary hypertension: endothelin receptor antagonists: update for the clinical nurse specialist.
O'Malley
Patricia
P
Miami Valley Hospital, Cardiology Services, Dayton, Ohio 45409, USA. pomalley@mvh.org
D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000077300:Bosentan; D004334:Drug Administration Schedule; D004346:Drug Information Services; D016903:Drug Monitoring; D065128:Endothelin Receptor Antagonists; D006207:Half-Life; D006801:Humans; D006976:Hypertension, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing / Q000503:physiopathology; D007555:Isoxazoles / Q000494:pharmacology / Q000627:therapeutic use; D009720:Nurse Clinicians / Q000458:organization & administration; D024802:Nurse's Role; D010353:Patient Education as Topic; D011652:Pulmonary Circulation / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome; D014655:Vascular Resistance / Q000187:drug effects
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D007555:Isoxazoles; D013449:Sulfonamides; D013876:Thiophenes; C106276:sitaxsentan; D000077300:Bosentan